Where are the blockbuster sales for oral sema??

[anonymous]

Soft launch to endos, head to head data with empa shows no difference in weight loss...giving away the drug to get market share...is this the worst launch ever of a product?? Endo reps need to step it up. PC is going to have to shove this bitter pill down IM's throats and they already are bucking it.

 

[anonymous]

This is a primary care drug. We are crushing it. It gives IM/PC a chance to act like doctors for once and not screw it up. We have had great acceptance and feedback. And it keeps all my jerk drs away from screwing up basal—-because they all either give 10 units forever or 110units and no meal time!

 

[anonymous]

This is a primary care drug. We are crushing it. It gives IM/PC a chance to act like doctors for once and not screw it up. We have had great acceptance and feedback. And it keeps all my jerk drs away from screwing up basal—-because they all either give 10 units forever or 110units and no meal time!

Don’t want to bring any more negative pricing and profit attention to us. We are already on the naughty list for insulin prices.

 

[anonymous]

SGLT2s will always come first

 

[anonymous]

sglt2i/glp1i is an ideal combo.

or if you prefer not to have gangrene of the genitals you can just use a glp1i post metformin.

 

[anonymous]

too many reps in my dirt selling RYBELSUS right now

 

[anonymous]

too many reps in my dirt selling RYBELSUS right now

Agreed, not sure why they moved the insulin reps over to GLP-1 portfolio it’s too much with them.

 

[anonymous]

if you don't understand that then you don't truly have a grasp of what is going on in our industry. No offense, but if you do work here I am surprised.

 

[anonymous]

Need share of voice now. 1/3 to 1/2 of sales will be laid off within 2 years